Author details

Full Name

Xiaodong Yang

Affiliation

ORCID

Career Start Year

2005

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
35733515	Wee1 kinase inhibitor adavosertib with radiation in newly diagnosed diffuse intrinsic pontine glioma: A Children's Oncology Group phase I consortium study.	Neurooncol Adv	2022
32672077	Precise engineering of Gemcitabine prodrug cocktails into single polymeric nanoparticles delivery for metastatic thyroid cancer cells.	Drug Delivery	2020
32294440	Phosphoglycerate Mutase 1 Activates DNA Damage Repair via Regulation of WIP1 Activity.	Cell Reports	2020
29760046	Dual HDAC and PI3K Inhibition Abrogates NFÎºB- and FOXM1-Mediated DNA Damage Response to Radiosensitize Pediatric High-Grade Gliomas.	Cancer Res	2018
29156677	Overcoming resistance to single-agent therapy for oncogenic <i>BRAF</i> gene fusions <i>via</i> combinatorial targeting of MAPK and PI3K/mTOR signaling pathways.	Oncotarget	2017
26384810	Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant glioma.	J Neurooncol	2016
26782702	Erratum to: Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant glioma.	J Neurooncol	2016
27217440	BRAF Status in Personalizing Treatment Approaches for Pediatric Gliomas.	Clin Cancer Res	2016
25695691	Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma.	Clin Cancer Res	2015
24305702	Targeting Wee1 for the treatment of pediatric high-grade gliomas.	Neuro Oncol	2014
23354848	Genotype-dependent cooperation of ionizing radiation with BRAF inhibition in BRAF V600E-mutated carcinomas.	Investigational New Drugs	2013
23482742	Poly (ADP-Ribose) polymerase inhibitor MK-4827 together with radiation as a novel therapy for metastatic neuroblastoma.	Anticancer Res	2013
21497989	Cooperation of the HDAC inhibitor vorinostat and radiation in metastatic neuroblastoma: efficacy and underlying mechanisms.	Cancer Lett	2011
21421857	Vorinostat increases expression of functional norepinephrine transporter in neuroblastoma in vitro and in vivo model systems.	Clin Cancer Res	2011
21317208	Inhibition of PI3K/mTOR pathways in glioblastoma and implications for combination therapy with temozolomide.	Neuro Oncol	2011
20964203	Radiation dose estimation using preclinical imaging with 124I-metaiodobenzylguanidine (MIBG) PET.	Med Phys	2010
18759130	Signal transduction molecules in gliomas of all grades.	J Neurooncol	2009
18413797	Characterization of structurally distinct, isoform-selective phosphoinositide 3'-kinase inhibitors in combination with radiation in the treatment of glioblastoma.	Mol Cancer Ther	2008
17346876	AN-113, a novel prodrug of 4-phenylbutyrate with increased anti-neoplastic activity in glioma cell lines.	Cancer Letters	2007
17347490	In vivo efficacy of a novel histone deacetylase inhibitor in combination with radiation for the treatment of gliomas.	Neuro Oncol	2007
16618745	Radiation-induced caspase-8 mediates p53-independent apoptosis in glioma cells.	Cancer Research	2006
16687487	Glucose withdrawal induces oxidative stress followed by apoptosis in glioblastoma cells but not in normal human astrocytes.	Molecular Cancer Research	2006
16373710	Butyric acid prodrugs are histone deacetylase inhibitors that show antineoplastic activity and radiosensitizing capacity in the treatment of malignant gliomas.	Mol Cancer Ther	2005